Cargando…
Pharmacotherapy for Status Epilepticus
Status epilepticus (SE) represents the most severe form of epilepsy. It is one of the most common neurologic emergencies, with an incidence of up to 61 per 100,000 per year and an estimated mortality of 20 %. Clinically, tonic-clonic convulsive SE is divided into four subsequent stages: early, estab...
Autores principales: | Trinka, Eugen, Höfler, Julia, Leitinger, Markus, Brigo, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/ https://www.ncbi.nlm.nih.gov/pubmed/26310189 http://dx.doi.org/10.1007/s40265-015-0454-2 |
Ejemplares similares
-
Efficacy and Safety of Intravenous Valproate for Status Epilepticus: A Systematic Review
por: Trinka, Eugen, et al.
Publicado: (2014) -
Unraveling the enigma of new‐onset refractory status epilepticus: a systematic review of aetiologies
por: Lattanzi, Simona, et al.
Publicado: (2021) -
Salzburg criteria for nonconvulsive status epilepticus: Details matter
por: Leitinger, Markus, et al.
Publicado: (2019) -
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
por: Höfler, Julia, et al.
Publicado: (2016) -
Clinical phenotypes within nonconvulsive status epilepticus
por: Lattanzi, Simona, et al.
Publicado: (2021)